| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 181,282 | 202,197 | 212,609 | 276,286 | | Cost of Revenue | 120,009 | 131,468 | 137,842 | 176,825 | | | Gross Profit | 61,273 | 70,729 | 74,767 | 99,461 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,366 | 50,142 | 51,763 | 57,513 | | Non Recurring | 110 | 2,073 | 6,239 | 4,625 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 16,797 | 18,514 | 16,765 | 37,323 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,112) | (2,747) | 1,324 | 1,801 | | Earnings Before Interest And Taxes | 13,685 | 15,767 | 18,089 | 39,124 | | Interest Expense | 4,054 | 2,856 | 2,771 | 3,626 | | Income Before Tax | 9,631 | 12,911 | 15,318 | 35,498 | | Income Tax Expense | 3,905 | 4,837 | 5,793 | 12,844 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,726 | 8,074 | 9,525 | 22,654 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,726 | 8,074 | 9,525 | 22,654 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,726 | $8,074 | $9,525 | $22,654 |
|
0.22% Nasdaq 
Income Statement
